Altogether, increasing galectin-3 levels were associated with occurrence of impaired systolic and diastolic cardiac function in T2DM as well as with an impaired systolic cardiac function in prediabetes, whereas no association was found in euglycaemic subjects. Here, LGALS3 is linked to type 2 diabetes mellitus.